Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Drug Card Roll-Out: Awareness Increasing, But Work To Do

Executive Summary

Medicare's drug discount card website is already driving an increase in calls to the program's toll-free phone number, CMS Administrator McClellan said

You may also be interested in...



Rx Price Comparisons Offered On Medicare Card Site For Eight Drug Classes

Medicare beneficiaries can compare the price of drugs in the same class for eight pharmaceutical categories following changes to the program's drug discount card website

Rx Price Comparisons Offered On Medicare Card Site For Eight Drug Classes

Medicare beneficiaries can compare the price of drugs in the same class for eight pharmaceutical categories following changes to the program's drug discount card website

CMS Drug Card Website Change Limits Results To Five “Best” Choices

Changes to the Medicare drug discount card website include limiting initial search results to the five cards offering the most savings

Related Content

UsernamePublicRestriction

Register

PS043718

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel